Scientific Publications by FDA Staff
J Bone Miner Res 1995 Jun;10(6):903-9
A comparison of the effects of parathyroid hormone and parathyroid hormone-related protein on osteocalcin in the rat.
Gundberg CM, Fawzi MI, Clough ME, Calvo MS
We compared the effects of parathyroid hormone (PTH1-34) and parathyroid hormone-related protein (PTHrp1-34) on osteocalcin release in the isolated rat hindlimb and in intact and thyroparathyroidectomized (TPTX) rats. PTH1-34 suppressed osteocalcin release from perfused rat hindquarters, while PTHrp1-34 had no effect on osteocalcin release, despite comparable stimulation of cAMP production. Similarly, serum osteocalcin declined in the intact and TPTX animals by 5 h after a single dose of PTH1-34, while there was no response to PTHrp1-34. Chronic administration of PTH1-34 or PTHrp1-34 produced comparable hypercalcemia and hypophosphatemia in sham-operated and TPTX animals. Chronic PTH1-34 administration produced significant increases in serum osteocalcin both in the sham-operated rats and in the TPTX animals. However, in animals chronically treated with PTHrp1-34, there was no change at any time point in osteocalcin in either sham-operated or TPTX rats. These differences could be inherent or merely due to potency differences between the two peptides.
|Category: Journal Article|
|PubMed ID: #7572314||DOI: 10.1002/jbmr.5650100611|
|Includes FDA Authors from Scientific Area(s): Food|
|Entry Created: 2012-11-12|